AllianceBernstein’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.99M | Sell |
149,327
-6,916
| -4% | -$165K | ﹤0.01% | 1648 |
|
|
2025
Q4 | $4.17M | Buy |
156,243
+1,250
| +0.8% | +$29.9K | ﹤0.01% | 1626 |
|
|
2025
Q3 | $3.31M | Sell |
154,993
-57
| -0% | -$1.35K | ﹤0.01% | 1724 |
|
|
2025
Q2 | $3.34M | Buy |
155,050
+9,770
| +7% | +$182K | ﹤0.01% | 1673 |
|
|
2025
Q1 | $2.41M | Sell |
145,280
-2,200
| -1% | -$40K | ﹤0.01% | 1797 |
|
|
2024
Q4 | $2.71M | Hold |
147,480
| – | – | ﹤0.01% | 1804 |
|
|
2024
Q3 | $2.27M | Hold |
147,480
| – | – | ﹤0.01% | 1896 |
|
|
2024
Q2 | $2.4M | Sell |
147,480
-401
| -0.3% | -$6.47K | ﹤0.01% | 1843 |
|
|
2024
Q1 | $2.73M | Buy |
147,881
+17,100
| +13% | +$424K | ﹤0.01% | 1749 |
|
|
2023
Q4 | $4.09M | Sell |
130,781
-520
| -0.4% | -$12.4K | ﹤0.01% | 1578 |
|
|
2023
Q3 | $2.74M | Sell |
131,301
-60,810
| -32% | -$1.65M | ﹤0.01% | 1707 |
|
|
2023
Q2 | $4.6M | Buy |
192,111
+39,910
| +26% | +$887K | ﹤0.01% | 1459 |
|
|
2023
Q1 | $2.86M | Sell |
152,201
-50,000
| -25% | -$952K | ﹤0.01% | 1678 |
|
|
2022
Q4 | $3.22M | Buy |
202,201
+50,000
| +33% | +$782K | ﹤0.01% | 1637 |
|
|
2022
Q3 | $2.49M | Sell |
152,201
-17,300
| -10% | -$280K | ﹤0.01% | 1741 |
|
|
2022
Q2 | $2.39M | Buy |
169,501
+15,900
| +10% | +$297K | ﹤0.01% | 1838 |
|
|
2022
Q1 | $3.72M | Sell |
153,601
-49,649
| -24% | -$1.2M | ﹤0.01% | 1730 |
|
|
2021
Q4 | $4.74M | Sell |
203,250
-73,800
| -27% | -$1.48M | ﹤0.01% | 1650 |
|
|
2021
Q3 | $4.6M | Buy |
277,050
+122,660
| +79% | +$2.36M | ﹤0.01% | 1651 |
|
|
2021
Q2 | $3.77M | Buy |
154,390
+69,561
| +82% | +$1.57M | ﹤0.01% | 1793 |
|
|
2021
Q1 | $2.19M | Sell |
84,829
-27,369
| -24% | -$1.2M | ﹤0.01% | 2045 |
|
|
2020
Q4 | $6M | Buy |
112,198
+33,299
| +42% | +$1.65M | ﹤0.01% | 1389 |
|
|
2020
Q3 | $3.25M | Sell |
78,899
-12,871
| -14% | -$556K | ﹤0.01% | 1582 |
|
|
2020
Q2 | $4.45M | Sell |
91,770
-149,999
| -62% | -$7.2M | ﹤0.01% | 1387 |
|
|
2020
Q1 | $10.2M | Sell |
241,769
-3,300
| -1% | -$136K | 0.01% | 904 |
|
|
2019
Q4 | $10.5M | Buy |
245,069
+30,580
| +14% | +$1.33M | 0.01% | 1069 |
|
|
2019
Q3 | $7.72M | Buy |
214,489
+50,790
| +31% | +$1.54M | ﹤0.01% | 1155 |
|
|
2019
Q2 | $4.38M | Buy |
163,699
+9,700
| +6% | +$248K | ﹤0.01% | 1503 |
|
|
2019
Q1 | $4.13M | Sell |
153,999
-69,741
| -31% | -$1.63M | ﹤0.01% | 1480 |
|
|
2018
Q4 | $3.62M | Buy |
223,740
+77,400
| +53% | +$1.5M | ﹤0.01% | 1479 |
|
|
2018
Q3 | $3.04M | Hold |
146,340
| – | – | ﹤0.01% | 1641 |
|
|
2018
Q2 | $2.23M | Buy |
146,340
+45,744
| +45% | +$816K | ﹤0.01% | 1832 |
|
|
2018
Q1 | $2.26M | Buy |
100,596
+2,309
| +2% | +$63.9K | ﹤0.01% | 1747 |
|
|
2017
Q4 | $2.96M | Sell |
98,287
-150
| -0.2% | -$4.8K | ﹤0.01% | 1578 |
|
|
2017
Q3 | $3.71M | Sell |
98,437
-58
| -0.1% | -$1.89K | ﹤0.01% | 1403 |
|
|
2017
Q2 | $2.75M | Sell |
98,495
-30,312
| -24% | -$903K | ﹤0.01% | 1612 |
|
|
2017
Q1 | $4.43M | Sell |
128,807
-120
| -0.1% | -$4.24K | ﹤0.01% | 1258 |
|
|
2016
Q4 | $3.72M | Sell |
128,927
-443
| -0.3% | -$11.7K | ﹤0.01% | 1383 |
|
|
2016
Q3 | $4.12M | Sell |
129,370
-4,900
| -4% | -$166K | ﹤0.01% | 1231 |
|
|
2016
Q2 | $4.36M | Sell |
134,270
-50,290
| -27% | -$1.68M | ﹤0.01% | 1141 |
|
|
2016
Q1 | $5.16M | Sell |
184,560
-1,356,372
| -88% | -$29.6M | ﹤0.01% | 1046 |
|
|
2015
Q4 | $54.9M | Buy |
1,540,932
+128,954
| +9% | +$4.54M | 0.05% | 427 |
|
|
2015
Q3 | $46.7M | Buy |
1,411,978
+1,261,578
| +839% | +$52.5M | 0.04% | 449 |
|
|
2015
Q2 | $6.3M | Hold |
150,400
| – | – | 0.01% | 1024 |
|
|
2015
Q1 | $4.9M | Buy |
150,400
+400
| +0.3% | +$13.7K | ﹤0.01% | 1133 |
|
|
2014
Q4 | $4.76M | Sell |
150,000
-3,400
| -2% | -$96.4K | ﹤0.01% | 1146 |
|
|
2014
Q3 | $3.8M | Hold |
153,400
| – | – | ﹤0.01% | 1235 |
|
|
2014
Q2 | $3.46M | Sell |
153,400
-69
| -0% | -$1.44K | ﹤0.01% | 1361 |
|
|
2014
Q1 | $3.73M | Buy |
153,469
+5,753
| +4% | +$146K | ﹤0.01% | 1295 |
|
|
2013
Q4 | $3.69M | Sell |
147,716
-6
| -0% | -$142 | ﹤0.01% | 1297 |
|
|
2013
Q3 | $4.06M | Buy |
147,722
+13,601
| +10% | +$284K | ﹤0.01% | 1186 |
|
|
2013
Q2 | $2.43M | Buy |
+134,121
| New | +$1.85M | ﹤0.01% | 1464 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI
AllianceBernstein's ACAD Position: Q1 2026 in Review
AllianceBernstein reduced its Acadia Pharmaceuticals (ACAD) stake by 4.4% in Q1 2026, selling an estimated $165K and leaving 149,327 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1648.
AllianceBernstein first reported a position in ACAD in Q2 2013 and has held it in 52 quarters since. The position peaked at $54.9M in Q4 2015. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.
- AllianceBernstein held 149,327 shares of Acadia Pharmaceuticals worth $3.99M as of Q1 2026.
- AllianceBernstein sold 6,916 Acadia Pharmaceuticals shares in Q1 2026, an estimated $165K.
- Acadia Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1648 holding.
- AllianceBernstein first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Acadia Pharmaceuticals position peaked at $54.9M in Q4 2015.
- 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.